|
2015 Journal Article Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALSKe, Yazi D., van Hummel, Annika, Stevens, Claire H., Gladbach, Amadeus, Ippati, Stefania, Bi, Mian, Lee, Wei S., Kruger, Sarah, van der Hoven, Julia, Volkerling, Alexander, Bongers, Andre, Halliday, Glenda, Haass, Nikolas K., Kiernan, Matthew, Delerue, Fabien and Ittner, Lars M. (2015). Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS. Acta Neuropathologica, 130 (5), 661-678. doi: 10.1007/s00401-015-1486-0 |
|
2015 Journal Article Corrigendum: a stress-induced early innate response causes multidrug tolerance in melanoma (vol 34, pg 4448, 2015)Menon, D. Ravindran, Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., Kashofer, K., Wagner, K., Zhang, G., Rad, E. Bonyadi, Haass, N. K., Soyer, H. P., Gabrielli, B., Somasundaram, R., Hoefler, G., Herlyn, M. and Schaider, H. (2015). Corrigendum: a stress-induced early innate response causes multidrug tolerance in melanoma (vol 34, pg 4448, 2015). Oncogene, 34 (34), 4545-4545. doi: 10.1038/onc.2014.432 |
|
2015 Journal Article A stress-induced early innate response causes multidrug tolerance in melanomaRavindran Menon, D., Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., Kashofer, K., Wagner, K., Zhang, G., Bonyadi Rad, E., Haass, N. K., Soyer, H. P., Gabrielli, B., Somasundaram, R., Hoefler, G., Herlyn, M. and Schaider, H. (2015). A stress-induced early innate response causes multidrug tolerance in melanoma. Oncogene, 34 (34), 4448-4459. doi: 10.1038/onc.2014.372 |
|
2015 Conference Publication MITF regulates proliferative subpopulation tumor architecture and modifies invasion and characteristics of the epithelial to mesenchymal transition within melanomaTonnessen, Crystal A., Beaumont, Kimberley A., Hill, David S., Daignault, Sheena M., Anfosso, Andrea, Jurek, Russell J., Weninger, Wolfgang and Haass, Nikolas K. (2015). MITF regulates proliferative subpopulation tumor architecture and modifies invasion and characteristics of the epithelial to mesenchymal transition within melanoma. 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia, PA, United States, 18-22 April 2015. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2015-1420 |
|
2015 Journal Article Dynamic tumor heterogeneity in melanoma therapy: how do we address this in a novel model system?Haass, Nikolas K. (2015). Dynamic tumor heterogeneity in melanoma therapy: how do we address this in a novel model system?. Melanoma Management, 2 (2), 93-95. doi: 10.2217/MMT.15.1 |
|
2015 Journal Article Friends or foes: IL-10 and TGF-beta in melanomaTikoo, Shweta and Haass, Nikolas K. (2015). Friends or foes: IL-10 and TGF-beta in melanoma. Experimental Dermatology, 24 (4), 254-255. doi: 10.1111/exd.12661 |
|
2015 Journal Article Expression of Bcl-xL and Mcl-1 in the Nonmelanoma Skin Cancers of Renal Transplant RecipientsBurke, Michael T., Morais, Christudas, Oliver, Kimberley A., Lambie, Duncan L. J., Gobe, Glenda C., Carroll, Robert P., Staatz, Christine E., Sinnya, Sudipta, Soyer, H. Peter, Winterford, Clay, Haass, Nikolas K., Campbell, Scott B. and Isbel, Nicole M. (2015). Expression of Bcl-xL and Mcl-1 in the Nonmelanoma Skin Cancers of Renal Transplant Recipients. American Journal of Clinical Pathology, 143 (4), 514-526. doi: 10.1309/AJCPQNB5WA3PLQBK |
|
2015 Conference Publication Targeting Rab27a to suppress melanoma proliferation and invasionBeaumont, K. A., Sharp, D. M., Weninger, W. and Haass, N. K. (2015). Targeting Rab27a to suppress melanoma proliferation and invasion. 42nd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Ulm, Germany, 05-07 March 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12623 |
|
2015 Book Chapter Cell cycle checkpoint and DNA damage response defects as anticancer targets: from molecular mechanisms to therapeutic opportunities.Spoerri, Loredana, Oo, Zay Yar, Larsen, Jill E., Haass, Nikolas K., Gabrielli, Brian and Pavey, Sandra (2015). Cell cycle checkpoint and DNA damage response defects as anticancer targets: from molecular mechanisms to therapeutic opportunities.. Stress response pathways in cancer: from molecular targets to novel therapeutics. (pp. 29-49) edited by Georg T. Wondrak. Dordrecht: Springer Science+Business Media. doi: 10.1007/978-94-017-9421-3_3 |
|
2015 Journal Article Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.Haass, Nikolas K., Nassif, Najah and McGowan, Eileen M. (2015). Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage.. BioMed Research International, 2015 165105, 165105.1-165105.9. doi: 10.1155/2015/165105 |
|
2015 Conference Publication Melanoma tumor sub-populations are defined by MITF expression, and exhibit enhanced proliferation and characteristics of an EMTTonnessen, C. A., Beaumont, K. A., Hill, D. S., Anfosso, A., Daignault, S. M., Fane, M., Jurek, R. J., Smith, A. G., Weninger, W. and Haass, N. K. (2015). Melanoma tumor sub-populations are defined by MITF expression, and exhibit enhanced proliferation and characteristics of an EMT. 42nd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Ulm, Germany, 05-07 March 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12623 |
|
2015 Conference Publication Making stressed melanoma self-destructHill, D. S., Beaumont, K. A., Daignault, S. M., Anfosso, A., Lovat, P. E., Weninger, W. and Haass, N. K. (2015). Making stressed melanoma self-destruct. Australasian College of Dermatologists 48th Annual Scientific Meeting, Adelaide, Australia, 16 May, 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12337 |
|
2015 Conference Publication An early innate stress response precedes acquired drug resistance in melanomaMenon, Dinoop Ravindran, Das, Suman, Krepler, Clemens, Vultur, Adina, Zhang, Gao, Haass, Nikolas, Soyer, Peter H., Gabrielli, Brian, Somasundaram, Rajasekharan, Hoefler, Gerald, Herlyn, Meenhard and Schaider, Helmut (2015). An early innate stress response precedes acquired drug resistance in melanoma. 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia Pa United States, April 18-22, 2015. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2015-2684 |
|
2015 Conference Publication Melanoma cells in G1 phase escape proteasome inhibitor cytotoxicityHill, D. S., Beaumont, K. A., Daignault, S. M., Anfosso, A., Sharp, D. M., Gabrielli, B., Lovat, P. E., Weninger, W. and Haass, N. K. (2015). Melanoma cells in G1 phase escape proteasome inhibitor cytotoxicity. 42nd Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Ulm, Germany, Mar 05-07, 2015. Chichester, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12623 |
|
2015 Book Chapter Melanoma: From tumor-specific mutations to a new molecular taxonomy and innovative therapeuticsTonnessen, Crystal A. and Haass, Nikolas K. (2015). Melanoma: From tumor-specific mutations to a new molecular taxonomy and innovative therapeutics. Personalized treatment options in dermatology. (pp. 7-27) edited by Thomas Bieber and Frank Nestle. Heidelberg, Germany: Springer. doi: 10.1007/978-3-662-45840-2_2 |
|
2014 Journal Article Induction of endoplasmic reticulum stress as a strategy for melanoma therapy: is there a future?Hill, David S., Lovat, Penny E. and Haass, Nikolas K. (2014). Induction of endoplasmic reticulum stress as a strategy for melanoma therapy: is there a future?. Melanoma Management, 1 (2), 127-137. doi: 10.2217/MMT.14.16 |
|
2014 Journal Article Targeting glutamine transport to suppress melanoma cell growthWang, Qian, Beaumont, Kimberley A., Otte, Nicholas J., Font, Josep, Bailey, Charles G., van Geldermalsen, Michelle, Sharp, Danae M., Tiffen, Jessamy C., Ryan, Renae M., Jormakka, Mika, Haass, Nikolas K., Rasko, John E. J. and Holst, Jeff (2014). Targeting glutamine transport to suppress melanoma cell growth. International Journal of Cancer, 135 (5), 1060-1071. doi: 10.1002/ijc.28749 |
|
2014 Journal Article Real-time cell cycle imaging during melanoma growth, invasion, and drug responseHaass, Nikolas K., Beaumont, Kimberley A., Hill, David S., Anfosso, Andrea, Mrass, Paulus, Munoz, Marcia A., Kinjyo, Ichiko and Weninger, Wolfgang (2014). Real-time cell cycle imaging during melanoma growth, invasion, and drug response. Pigment Cell and Melanoma Research, 27 (5), 764-776. doi: 10.1111/pcmr.12274 |
|
2014 Journal Article Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up studyMoloney, Fergal J., Guitera, Pascale, Coates, Elliot, Haass, Nikolas K., Ho, Kenneth, Khoury, Ritta, O'Connell, Rachel L., Raudonikis, Leo, Schmid, Helen, Mann, Graham J. and Menzies, Scott W. (2014). Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study. JAMA Dermatology, 150 (8), 819-827. doi: 10.1001/jamadermatol.2014.514 |
|
2014 Journal Article Melanoma never says dieHaass, Nikolas K. and Schumacher, Udo (2014). Melanoma never says die. Experimental Dermatology, 23 (7), 471-472. doi: 10.1111/exd.12400 |
